Everest Biolabs, Inc.

CIK 2116676 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Everest Biolabs, Inc..

Recent SEC filings

FiledFormAccession number
Mar 11, 2026D0002116676-26-000001